mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾

OAÈë¿Ú
±¨¸æµ¥ÅÌÎÊ
ÔÚÏ߿ͷþ
mg±ùÇòÍ»ÆÆ(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÐÂÎÅÖÐÐÄ
News Center
ÇÄÇēDZÔÚ” £¬×îÖÕ¿ÉÄÜÉú³¤³É“Äò¶¾Ö¢”£¡ÕâÀàÉöÔಡӦÌáǰɸ²é
Ðû²¼£º2024/03/14

ÉöÔಡÊÇÒ»Öָ߷¢¼²²¡ £¬ÌìϹæÄ£ÄÚÆ½¾ùÿ10¸ö³ÉÄêÈËÖоÍÓÐ1ÈË»¼ÓÐÂýÐÔÉöÔಡ £¬ÆäÒý·¢µÄéæÃüÂÊÒ»Á¬ÉÏÉý £¬Ô¤¼Æµ½2040Ä꽫»á³ÉΪµÚÎå´óËÀÒò¡£½ñÌìÊǵÚ19¸öÌìÏÂÉöÔàÈÕ £¬ÈÃÎÒÃÇÒ»Æð¹Ø×¢ÕâÀàÌØÊâµÄÉöÔ༲²¡¡­¡­


һλ32ËêµÄÄÐÊ¿ÔÚÌå¼ìʱ·¢Ã÷ÉöÔàÉÏÓÐÄÒÖס£Ëû¸æËßÌå¼ì±¨¸æ½â¶ÁÒ½Éú £¬×Ô¼ºµÄÂèÂèÊÇһλ¶àÄÒÉö²¡»¼Õß¡£ÎªÁ˽øÒ»²½Ã÷È·Õï¶Ï £¬ÔÚÒ½Éú½¨ÒéÏ £¬Ëû×öÁËÏà¹Ø»ùÒò¼ì²â¡£×ÛºÏmg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾³ö¾ßµÄ¼ì²â±¨¸æºÍÒÅ´«×ÉѯʦÆÊÎö £¬¼ì³öËûµÄPKD1»ùÒòÓÐÒÉËÆÖ²¡±äÒ죨NM_001009944.3 c.10796C>G p.Ser3599Ter exon36£© £¬¸Ã±äÒìÒ²ÓëÆäÏÖÔÚµÄÁÙ´²ÐÅÏ¢Ò»Ö¡£


ͨ¹ýÉÏÊö·¢Ã÷ £¬×îÖÕÕï¶ÏÕâλÄÐʿ¼µÄÊdz£È¾É«ÌåÏÔÐÔ¶àÄÒÉö¡£ÕâÊÇÒ»ÖÖ×î³£¼ûµÄÒÅ´«ÐÔÉö²¡Ö®Ò» £¬·¢²¡ÂÊԼΪ1/1000ÇÒ»áËæ×ÅÄêËêÔöÌí¶øÔöÌí¡£Ô¼Äª50%µÄ»¼ÕßÔÚ60Ëêʱ»¼ÓÐÖÕÄ©ÆÚÉö²¡ £¬Ò²¾ÍÊÇ¡°Äò¶¾Ö¢¡±¡£



ΪʲôÒÅ´«ÐÔÉö²¡ÄÑÒÔÔçÆÚ²ì¾õ£¿


ÔÚµ¼ÖÂÖÕÄ©ÆÚÉö²¡µÄÔµ¹ÊÔ­ÓÉÖÐ £¬ÒÅ´«ÐÔÉö²¡ÅÅÃûµÚÎå £¬½ô¸úÔÚÂýÐÔÉöÑס¢ÌÇÄò²¡Éö²¡µÈÖ®ºó¡£ÓÐԼĪ10%-15%µÄÉöÔಡ»¼Õß¶¼ÊÇÓÉÓÚÒÅ´«ÒòËØ»¼²¡ £¬ÌØÊâÊÇÔÚÄêÇáÈ˺ͶùͯȺÌåÖиüΪͻ³ö¡£ºÃ±È £¬ÔÚ25Ëêǰ»¼ÂýÐÔÉö²¡µÄÈËȺÖÐ £¬Ã¿5¸ö¾ÍÓÐ1¸öÊÇÒÅ´«ÐÔÉö²¡ £»¶øÔÚÐèÒª¾ÙÐжùͯÉöÒÆÖ²µÄ²¡ÀýÖÐ £¬Èý³ÉÒÔÉ϶¼ÓëÒÅ´«ÓйØ¡£


ÒÅ´«ÐÔÉö²¡ÓÐ×ÅÖØ´óµÄ»ùÒòÅä¾°¡ª¡ªÏÖÔÚÒÑÖªÖ²¡»ùÒòÁè¼Ý600¸ö £¬²¢ÇÒÒÅ´«·½·¨¶àÖÖ¶àÑù £¬ÓеÄÊÇÏÔÐÔÒÅ´« £¬ÓеÄÊÇÒþÐÔÒÅ´«¡£ÕâÒâζ×Å £¬Ðí¶àÒÅ´«ÐÔÉö²¡ÔÚ³õÆÚ½×¶ÎÍùÍùÖ¢×´²»ÏÔ×Å»òÕßÓëÆäËûÀàÐÍÉö²¡ÏàËÆ £¬²»Ò×±»Ê¶±ð³öÀ´ £¬ÉõÖÁÓÐʱֱµ½²¡ÇéÉú³¤µ½Éö¹¦Ð§Ë¥½ßµÄÌïµØ²Å±»È·Õï¡£


±ðµÄ £¬ÉÐÓÐÐí¶à¹ýʧµÄ¿´·¨Ò²ÔÚÎóµ¼×Å»¼Õߣº¡°ÒÅ´«ÐÔÉö²¡¾ÍÊÇÏÈÌìÐÔÉö²¡ £¬ÎÒ¶¼¼¸Ê®ËêÁ˲ŵõÄÉö²¡ £¬Ò»¶¨²»ÊÇÒÅ´«²¡¡£¡±¡°âïÊѶ¼Ã»²¡ £¬ÎÒÒ»¶¨²»ÊÇÒÅ´«²¡¡£¡±ÊÂʵÉÏ £¬ÒÅ´«²¡¼È¿ÉÒÔÊÇÓ¤Ó×¶ùʱÆÚ·¢²¡ £¬Ò²»áÍíÖÁ¼¸Ê®ËêÉõÖÁÍíÄêʱ²ÅÊ×´ÎÕ¹ÏÖ²¡Ö¢¡£ÒÔÊÇ £¬ÏÖÔÚ¿´ÆðÀ´¿µ½¡µÄÈË £¬Ò²ÓпÉÄÜЯ´øÖ²¡»ùÒò¶ø²»×ÔÖª £¬²¢½«Õâ¸öΣº¦ÇÄÎÞÉùÏ¢µØ´«¸øÏÂÒ»´ú¡£



»ùÒò¼ì²âÖúÁ¦ÒÅ´«ÐÔÉö²¡ÔçÕï¶Ï


»ùÒò¼ì²âÊÖÒÕͨ¹ý¼ì²âÈËÌåDNAÖеıäÒì £¬Äܹ»×¼È·Ê¶±ðÓëÒÅ´«ÐÔÉö²¡Ïà¹ØµÄÌØ¶¨»ùÒòÍ»±ä £¬ÊµÏÖ¼²²¡µÄÔçÆÚ¡¢¾«×¼Õï¶Ï £¬¿ÉÒÔÖ»¹Ü×èÖ¹½öÒÀÀµÁÙ´²Ö¢×´µ¼ÖµÄÎóÕï»òÑÓ³ÙÕï¶Ï¡£


ÄÄЩÉö²¡»¼Õß½¨Òé×ö»ùÒò¼ì²â£¿


1.ÁÙ´²ÌåÏÖÀàËÆÒÅ´«ÐÔ¼²²¡ £»

2.ÓÐÃ÷È·µÄÒÅ´«ÇãÏò £»

3.ÓмÒ×åÊ· £»

4.ͨÀýµÄÁÙ´²Á÷³ÌÄÑÒÔÈ·Õï £»

5.ÔçÆÚÕï¶ÏÓÐÖúÓÚÔ¤·ÀÐÔ¸ÉÔ¤ £»

6.ÌØÊâµÄµØÇøºÍÖÖ×å¡£


¼ò¶øÑÔÖ® £¬¹ØÓÚÄÇЩÔçÆÚ·¢²¡¡¢Õï¶Ï²»Ã÷¡¢ÖÎÁÆÐ§¹û²»¼Ñ¡¢ÏÓÒɾßÓÐÒÅ´«ÐÔ×Ó»òÓмÒ×åÉö²¡Ê·µÄ»¼Õß £¬¶¼½¨Òé˼Á¿¾ÙÐлùÒò¼ì²â¡£



»ùÒò¼ì²âÔÚÒÅ´«ÐÔÉö²¡ÕïÁÆÖеÄ×÷ÓÃ


1.ÅжÏÏêϸÀàÐÍ £¬Ö¸µ¼ÖÎÁÆÆ«Ïò £¬ÅжÏÔ¤ºó¡£

  • ׼ȷʶ±ðÒÅ´«ÐÔÉö²¡µÄÀàÐÍ £¬Îª»¼ÕßÌṩÕë¶ÔÐÔµÄÖÎÁƼƻ®¡£²¿·ÖÒÅ´«ÐÔÉö²¡ÈçÊÊÓø¨Ã¸Q10¡¢Íз¥ÆÕ̹µÈÒ©ÎïÖÎÁƵÄÇéÐÎ £¬Í¨¹ý¼ì²â¿ÉÃ÷È·ÓÃÒ©Ñ¡Ôñ £»Í¬Ê±×èÖ¹ÎÞЧÖÎÁÆ £¬¼õÇá¾­¼Ã¼ç¸ººÍÒ©Î︱×÷Óá£

  • ×ÊÖúÕ¹Íû¼²²¡Éú³¤Àú³Ì £¬ÊÊʱÆô¶¯¸ÉÔ¤²½·¥ £¬×ÊÖúÔ¤¹ÀÉöË¥½ßµÄ±¬·¢Ê±¼ä £¬ÒÔ±ãÊµÊ±ÖÆ¶©¸öÐÔ»¯Ò½ÁÆÕ½ÂÔ¡£

  • ÓÐÖúÓÚÒ½Éú¸üºÃµØÆÀ¹ÀÉöÒÆÖ²ÊÖÊõµÄÀÖ³ÉÂʼ°ºóÐø¹ÜÀí¡£


2.ɸ²é¼ÒÍ¥¸ßΣ³ÉÔ± £¬Ö¸µ¼ÓÅÉúÓÅÓý¡£

  • ¿ÉÕ¹ÏÖ¼Ò×åÖÐÆäËû³ÉÔ±µÄ»¼²¡Î£º¦¡£

  • ¹ØÓÚÓÐÉúÓýÍýÏëµÄ¼ÒÍ¥À´Ëµ £¬¿Éͨ¹ý»ùÒò¼ì²â¾ÙÐÐÅßÌ¥Ö²Èëǰ»ò²úǰÒÅ´«É¸²é £¬ÌáǰµÃÖª×ÓÅ®ÊÇ·ñЯ´øÖ²¡»ùÒò £¬ÊµÏÖÓÅÉúÓÅÓý¡£



»ùÒò¼ì²âÔõô×ö£¿


ÉöÔàÏà¹Ø»ùÒò¼ì²âͨ³£Í¨¹ý¼òÆÓµÄ³éѪÀ´»ñÈ¡Ñù±¾ £¬ÊܼìÈËÎÞÐèÌØÊâ×¼±¸ £¬¿Õ¸¹¡¢ÓÃÒ©µÈ¾ù²»Ó°ÏìÑù±¾¡£µ«ÎªÁ˸üºÃµØÃ÷È·Õï¶Ï £¬ËͼìÕßÐèÌṩÏ꾡µÄ²¡Ê·ºÍÁÙ´²×ÊÁÏ¡£mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾¿ÉÌṩÒÅ´«ÐÔÉö²¡Õï¶ÏÕûÌå½â¾ö¼Æ»® £¬²¢ÓÉרҵµÄÒÅ´«×ÉѯʦÍŶÓÌṩ±¨¸æ½â¶Á·þÎñ¡£

ÏîÄ¿±í.jpg

mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾ÉöÔಡÏà¹Ø»ùÒò¼ì²âÏîÄ¿


mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾³Ð¼Ì¡°ÁÙ´²±íÐÍ+¾­¼Ã¸ßЧ¡±µÄ»ùÒòÕï¶ÏÀíÄî £¬ÔÚÌá¸ßÒÅ´«ÐÔÉö²¡¼ì²âˮƽµÄͬʱ £¬³ä·ÖÍŽỼÕßµÄÁÙ´²ÌåÏÖÌØÕ÷¼°ÒÅ´«Åä¾°ÐÅÏ¢ £¬ÖúÁ¦Ò½Éú¸ü׼ȷµØÕï¶Ï¼²²¡ÀàÐͺÍÕ¹Íû¼²²¡Éú³¤Ç÷ÊÆ £¬´Ó¶øÎª»¼ÕßÌṩÕë¶ÔÐÔÖÎÁÆ £¬ÓÐÓüõÇá¼²²¡ÕïÁÆÀú³ÌÖеľ­¼Ã¼ç¸º¡£


³ýÁËͨ¹ý»ùÒò¼ì²âÖúÁ¦ÒÅ´«ÐÔÉö²¡ÔçÕï¶Ï £¬mg±ùÇòÍ»ÆÆ¹ÙÍøÍøÕ¾ÔçÒѽ¨ÉèÉöÔಡ¼ì²âÖÐÐÄ £¬ÒÔ±ê×¼»¯ºÍ¹æ·¶»¯µÄÉö»î¼ì²¡Àí¼ì²é¼°±¨¸æÏµÍ³Îª»ù´¡ £¬Á¢ÒìÈÚºÏÊý×Ö»¯²¡ÀíÊÖÒÕºÍÍøÂçÆ½Ì¨ÓÅÊÆ £¬ÎªÁÙ´²Õï¶Ï¡¢ÁÙ´²ÊÔÑéÓë¿ÆÑС¢ÐÂÖÎÁưеãµÄѰÕÒµÈÌṩ¼ì²â·þÎñ £¬ÖúÁ¦ÁÙ´²Öƶ©ÖÖÖÖÉöÔ༲²¡µÄ¸öÌ廯ÖÎÁƼƻ®¡£


²Î¿¼ÎÄÏ×


[1]M¨¹ller RU, Messchendorp AL, Birn H, et al. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant. 2022 Apr 25;37(5):825-839.

[2]ÐìµÂ³¬,÷³¤ÁÖ. ¶àÄÒÉö²¡µÄÁÙ´²Êµ¼ùÖ¸ÄÏ[J]. ÖлªÒ½Ñ§ÒÅ´«Ñ§ÔÓÖ¾, 2020(3): 277-283.

[3]Íз¥ÆÕ̹ÖÎÁÆ¿ìËÙÏ£ÍûÐͳ£È¾É«ÌåÏÔÐÔ¶àÄÒÉö²¡×¨¼Ò×é. Íз¥ÆÕ̹ÖÎÁÆ¿ìËÙÏ£ÍûÐͳ£È¾É«ÌåÏÔÐÔ¶àÄÒÉö²¡Öйúר¼Ò¹²Ê¶[J]. ÖлªÉöÔಡÔÓÖ¾, 2022, 38(7): 644-652.


ÍøÕ¾µØÍ¼